![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NDST3 |
Gene summary for NDST3 |
![]() |
Gene information | Species | Human | Gene symbol | NDST3 | Gene ID | 9348 |
Gene name | N-deacetylase and N-sulfotransferase 3 | |
Gene Alias | HSST3 | |
Cytomap | 4q26 | |
Gene Type | protein-coding | GO ID | GO:0000271 | UniProtAcc | O95803 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9348 | NDST3 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.76e-04 | 3.30e-01 | -0.1088 |
9348 | NDST3 | HTA11_347_2000001011 | Human | Colorectum | AD | 7.81e-10 | 3.80e-01 | -0.1954 |
9348 | NDST3 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.84e-09 | 3.69e-01 | -0.1464 |
9348 | NDST3 | HTA11_866_2000001011 | Human | Colorectum | AD | 2.80e-03 | 1.66e-01 | -0.1001 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0044262 | Colorectum | AD | cellular carbohydrate metabolic process | 87/3918 | 283/18723 | 6.00e-05 | 1.01e-03 | 87 |
GO:0006790 | Colorectum | AD | sulfur compound metabolic process | 101/3918 | 339/18723 | 6.46e-05 | 1.07e-03 | 101 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NDST3 | SNV | Missense_Mutation | novel | c.916C>A | p.Leu306Ile | p.L306I | O95803 | protein_coding | deleterious(0.02) | probably_damaging(0.999) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
NDST3 | SNV | Missense_Mutation | c.1274C>T | p.Ser425Leu | p.S425L | O95803 | protein_coding | deleterious(0) | probably_damaging(0.943) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response | |
NDST3 | SNV | Missense_Mutation | novel | c.2006C>T | p.Ala669Val | p.A669V | O95803 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
NDST3 | SNV | Missense_Mutation | novel | c.755C>A | p.Ala252Asp | p.A252D | O95803 | protein_coding | tolerated(0.14) | possibly_damaging(0.493) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
NDST3 | SNV | Missense_Mutation | novel | c.1202T>C | p.Ile401Thr | p.I401T | O95803 | protein_coding | tolerated(0.63) | benign(0.014) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
NDST3 | SNV | Missense_Mutation | novel | c.2498N>A | p.Ser833Tyr | p.S833Y | O95803 | protein_coding | tolerated(0.19) | possibly_damaging(0.516) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
NDST3 | SNV | Missense_Mutation | novel | c.599N>T | p.Pro200Leu | p.P200L | O95803 | protein_coding | deleterious(0.02) | probably_damaging(0.969) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
NDST3 | SNV | Missense_Mutation | c.332N>T | p.Ala111Val | p.A111V | O95803 | protein_coding | tolerated(0.21) | benign(0.11) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NDST3 | SNV | Missense_Mutation | novel | c.65G>A | p.Cys22Tyr | p.C22Y | O95803 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.992) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NDST3 | SNV | Missense_Mutation | c.1781N>A | p.Arg594His | p.R594H | O95803 | protein_coding | tolerated(0.09) | benign(0.001) | TCGA-EY-A2OP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |